FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 107 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,129 | -99.9% | 341,972 | -16.7% | 0.11% | -9.8% |
Q1 2023 | $1,170,535 | -60.9% | 410,714 | 0.0% | 0.12% | -66.8% |
Q4 2022 | $2,989,998 | -10.0% | 410,714 | 0.0% | 0.37% | -10.2% |
Q3 2022 | $3,323,000 | +65.2% | 410,714 | 0.0% | 0.41% | +77.3% |
Q2 2022 | $2,012,000 | -79.3% | 410,714 | 0.0% | 0.23% | -76.2% |
Q1 2022 | $9,713,000 | +33.7% | 410,714 | 0.0% | 0.98% | +43.7% |
Q4 2021 | $7,266,000 | -37.3% | 410,714 | 0.0% | 0.68% | +0.4% |
Q3 2021 | $11,586,000 | +169.2% | 410,714 | 0.0% | 0.68% | +173.8% |
Q2 2021 | $4,304,000 | -11.0% | 410,714 | 0.0% | 0.25% | -8.1% |
Q1 2021 | $4,838,000 | +0.6% | 410,714 | 0.0% | 0.27% | +3.4% |
Q4 2020 | $4,809,000 | +47.7% | 410,714 | 0.0% | 0.26% | +45.8% |
Q3 2020 | $3,257,000 | -56.6% | 410,714 | 0.0% | 0.18% | -72.1% |
Q2 2020 | $7,512,000 | +53.2% | 410,714 | 0.0% | 0.64% | -16.4% |
Q1 2020 | $4,904,000 | -28.2% | 410,714 | 0.0% | 0.77% | +6.1% |
Q4 2019 | $6,834,000 | +150.6% | 410,714 | 0.0% | 0.72% | +184.6% |
Q3 2019 | $2,727,000 | – | 410,714 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |